Synokem Lifesciences Pvt Ltd Walk-in Interview 2024.Synokem Lifesciences Pvt Ltd Notification full details below.Interested and eligible candidates can attend Interview on scheduled time and venue… Vacancy details: Department: QA, QC & R&D (ADL) For our OSD (Haridwar) & Injectable Facility (Paonta Sahib). Experience:02-8 years Salary:₹Not Disclosed …
Piramal Pharma Limited (PPL) Walk-in Interview 2024.Piramal Pharma Limited (PPL) Notification full details below.Interested and eligible candidates can attend Interview on scheduled time and venue. Vacancy details: Department: AR&D/TSD/Mechanical/Instrumentation/Prodcution Experienced: 2-10 years’ experience Qualification: B.Tech/B.E/Bsc/Msc Important Details : Location: Hyderabad Post of date:18/12/2024 Selection Process: The …
Merck announces FDA acceptance of biologics license application for Clesrovimab An investigational long-acting monoclonal antibody designed to protect infants from RSV disease during their first RSV season Merck today announced the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for clesrovimab …
Rusan Pharma achieves GMP approvals from TGA (Australia) and ANVISA (Brazil) for its manufacturing facility in Kandla SEZ The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market Rusan Pharma Ltd, a leading global pharmaceutical company specialising in addiction treatment and …
Caplin Steriles gets USFDA approval for Difluprednate Ophthalmic emulsion Difluprednate Ophthalmic Emulsion, 0.05% is a topical corticosteroid that is indicated in the treatment of inflammation and pain associated with ocular surgery Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited, has been granted …
Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, (GPI), has received approval from the U.S. Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine Dimesylate Chewable Tablets. The approved drug is …
In yet another US patient at Houston Methodist Hospital, Texas, Zaynich turned out to be a saviour by successfully clearing a chronic bile duct infection, facilitating liver transplant leading to her discharge from the hospital. As per the treating doctor, patient failed to respond to >6 …
Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
error: Content is protected !!
